AIP
ORKA icon

Ameritas Investment Partners’s Oruka Therapeutics ORKA Stock Holding History

Ameritas Investment Partners’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$435K Buy
4,572
+1,440
+46% +$95.9K 0.01% 959
2026
Q1 		$154K Hold
3,132
– – ﹤0.01% 1421
2025
Q4 		$94.9K Buy
3,132
+355
+13% +$9.89K ﹤0.01% 1740
2025
Q3 		$53.4K Hold
2,777
– – ﹤0.01% 2074
2025
Q2 		$31.1K Buy
+2,777
New +$28.9K ﹤0.01% 2464

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Ameritas Investment Partners's ORKA Position: Q2 2026 in Review

Ameritas Investment Partners increased its Oruka Therapeutics (ORKA) stake by 46% in Q2 2026, buying an estimated $95.9K and bringing the position to 4,572 shares worth $435K. The position accounts for 0.01% of the portfolio, ranked #959.

Ameritas Investment Partners first reported a position in ORKA in Q2 2025 and has held it in 5 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Ameritas Investment Partners held 4,572 shares of Oruka Therapeutics worth $435K as of Q2 2026.
  • Ameritas Investment Partners bought 1,440 Oruka Therapeutics shares in Q2 2026, an estimated $95.9K.
  • Oruka Therapeutics made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #959 holding.
  • Ameritas Investment Partners first reported a position in Oruka Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.